Regeneron Pharmaceuticals (REGN) Capital Expenditures Growth (3y) (2012 - 2026)
Regeneron Pharmaceuticals (REGN) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 46.88% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 8.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.97% |
| Dec 31, 2025 | 17.78% |
| Sep 30, 2025 | 48.95% |
| Jun 30, 2025 | -32.55% |
| Mar 31, 2025 | 17.38% |
| Dec 31, 2024 | 8.82% |
| Sep 30, 2024 | 44.84% |
| Jun 30, 2024 | -54.59% |
| Mar 31, 2024 | 21.42% |
| Dec 31, 2023 | 15.92% |
| Sep 30, 2023 | 36.75% |
| Jun 30, 2023 | -40.80% |
| Mar 31, 2023 | 1.56% |
| Dec 31, 2022 | 3.07% |
| Sep 30, 2022 | 5.40% |
| Jun 30, 2022 | 17.53% |
| Mar 31, 2022 | 24.04% |
| Dec 31, 2021 | 21.91% |
| Sep 30, 2021 | 7.84% |
| Jun 30, 2021 | 19.06% |